Use of random systematic mutagenesis to generate viable human rhinovirus 14 chimeras displaying human immunodeficiency virus type 1 V3 loop sequences
- PMID: 8254775
- PMCID: PMC236325
- DOI: 10.1128/JVI.68.1.575-579.1994
Use of random systematic mutagenesis to generate viable human rhinovirus 14 chimeras displaying human immunodeficiency virus type 1 V3 loop sequences
Abstract
Random systematic mutagenesis was used to generate a library of human rhinovirus 14 chimeras that each display a segment from the V3 loop of human immunodeficiency virus type 1. The sequence XXIGPGRAXX, where X could be any of the 20 amino acids, was inserted at the neutralizing immunogenic site II of human rhinovirus 14 between VP2 residues 159 and 160. Twenty-five unique chimeric viruses were isolated, and the identity of their randomized residues was determined. A nonrandom amino acid distribution that may reflect structural requirements for viability was observed at the randomized positions. Fifteen of 25 chimeras were neutralized by one or more of a panel of four anti-human immunodeficiency virus type 1 V3 loop antibody preparations, indicating that antigenicity had been successfully transplanted. Libraries of chimeric viruses produced by using the techniques described may be a source of vaccines and other immunotherapeutic reagents. The random systematic mutagenesis methodology described should be generally useful for the rapid transplantation of foreign sequences into viral coat and other proteins to produce libraries containing members with the desired properties.
Similar articles
-
Chimeras from a human rhinovirus 14-human immunodeficiency virus type 1 (HIV-1) V3 loop seroprevalence library induce neutralizing responses against HIV-1.J Virol. 1995 Apr;69(4):2406-11. doi: 10.1128/JVI.69.4.2406-2411.1995. J Virol. 1995. PMID: 7884887 Free PMC article.
-
Libraries of human rhinovirus-based HIV vaccines generated using random systematic mutagenesis.AIDS Res Hum Retroviruses. 1994;10 Suppl 2:S47-52. AIDS Res Hum Retroviruses. 1994. PMID: 7865333 Review.
-
A disulfide-bound HIV-1 V3 loop sequence on the surface of human rhinovirus 14 induces neutralizing responses against HIV-1.Biol Chem. 1999 Mar;380(3):365-74. doi: 10.1515/BC.1999.048. Biol Chem. 1999. PMID: 10223339
-
Human rhinovirus type 14:human immunodeficiency virus type 1 (HIV-1) V3 loop chimeras from a combinatorial library induce potent neutralizing antibody responses against HIV-1.J Virol. 1998 Jan;72(1):651-9. doi: 10.1128/JVI.72.1.651-659.1998. J Virol. 1998. PMID: 9420270 Free PMC article.
-
Protein engineering to create biologically active peptides: recombinant human rhinoviruses that display peptide sequences.Behring Inst Mitt. 1997 Feb;(98):229-39. Behring Inst Mitt. 1997. PMID: 9382744 Review.
Cited by
-
Use of macromolecular assemblies as expression systems for peptides and synthetic vaccines.Curr Opin Struct Biol. 1996 Apr;6(2):176-82. doi: 10.1016/s0959-440x(96)80072-8. Curr Opin Struct Biol. 1996. PMID: 8728650 Free PMC article. Review.
-
Chimeras from a human rhinovirus 14-human immunodeficiency virus type 1 (HIV-1) V3 loop seroprevalence library induce neutralizing responses against HIV-1.J Virol. 1995 Apr;69(4):2406-11. doi: 10.1128/JVI.69.4.2406-2411.1995. J Virol. 1995. PMID: 7884887 Free PMC article.
-
Chimeric rhinoviruses displaying MPER epitopes elicit anti-HIV neutralizing responses.PLoS One. 2013 Sep 6;8(9):e72205. doi: 10.1371/journal.pone.0072205. eCollection 2013. PLoS One. 2013. PMID: 24039745 Free PMC article.
-
Antigenic characteristics of rhinovirus chimeras designed in silico for enhanced presentation of HIV-1 gp41 epitopes [corrected].J Mol Biol. 2010 Apr 2;397(3):752-66. doi: 10.1016/j.jmb.2010.01.064. Epub 2010 Feb 4. J Mol Biol. 2010. PMID: 20138057 Free PMC article.
-
Broad neutralization of human immunodeficiency virus type 1 (HIV-1) elicited from human rhinoviruses that display the HIV-1 gp41 ELDKWA epitope.J Virol. 2009 May;83(10):5087-100. doi: 10.1128/JVI.00184-09. Epub 2009 Mar 11. J Virol. 2009. PMID: 19279101 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources